glp-1 market size Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Growth
Description
The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects
A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)
Shima Hadidchi MD Offered Semaglutide GLP-1 Injections to Help Obese Adults to Achieve Substantial Weight Loss & Improved Overall Health.
Compare early results with Wegovy and Mounjaro.
News and information for journalists
